It’s with an enormous sense of pride, satisfaction, and relief that I can share that @MAPS learned that the first of two Phase 3 studies of MDMA-assisted psychotherapy for PTSD was statistically significant and is considered a successful Phase 3 study: maps.org/20201217a
